Abstract
The development and application of the CRISPR-Cas9 technology for genome editing of mammalian cells have opened up a wealth of possibilities for genetically modifying and manipulating human cells, and use in functional studies or therapeutic approaches.Here we describe the approach that we have been using successfully to generate multiple human cell lines with targeted (partial) gene deletions, i.e., knockout cells, or human cells with modified genomic nucleotide sequences, i.e., knock-in cells, in genes encoding known or putative proteins involved in peroxisome biogenesis or peroxisomal functions.
Original language | English |
---|---|
Pages (from-to) | 233-245 |
Number of pages | 13 |
Journal | Methods in molecular biology (Clifton, N.J.) |
Volume | 2643 |
DOIs | |
Publication status | Published - 2023 |
Externally published | Yes |